Hai Hua Bu
Chief Executive Officer at Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Hai Hua Bu active positions
| Companies | Position | Start | End |
|---|---|---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
 Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Director/Board Member | - | - |
| Hepalink (Hong Kong) Co., Ltd. | Director/Board Member | - | - |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Career history of Hai Hua Bu
Former positions of Hai Hua Bu
| Companies | Position | Start | End |
|---|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Director/Board Member | 30/11/2006 | 16/04/2021 |
| Corporate Secretary | 30/11/2006 | 17/09/2020 |
Training of Hai Hua Bu
| Shanghai Jiao Tong University | Masters Business Admin |
| Shanghai University of Finance & Economics | Undergraduate Degree |
Statistics
International
| China | 6 |
| Hong Kong | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Secretary | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
| Private companies | 3 |
|---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |
| Hepalink (Hong Kong) Co., Ltd. | |
| Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
- Stock Market
- Insiders
- Hai Hua Bu
- Experience
